Last week’s hot topic on endometriosis was Endometriosis Patients in US Gain Access to Norethindrone Acetate Tablets written by Charles Moore.
This article is about Aurobindo Pharma Limited, who recently announced that the company has received final approval from the U.S. Food and Drug Administration (FDA) to manufacture and market norethindrone acetate tablets (5 mg) in the United States. The tablets are used to treat endometriosis, uterine bleeding caused by abnormal hormone levels, and secondary amenorrhea.
Read more about endometriosis: http://bit.ly/learnEndometriosis